Texas Instruments Incorporated (TXN) Stock Forecast
Data as of May 2, 2026Technology · Current price $281.46 (+0.13%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 16, 2026 | Vijay Rakesh | Mizuho Securities | $215.00 | -23.6% |
| Feb 23, 2026 | Matthew Prisco | Cantor Fitzgerald | $250.00 | -11.2% |
| Jan 28, 2026 | Timothy Arcuri | UBS | $260.00 | -7.6% |
| Jan 28, 2026 | Tristan Gerra | Robert W. Baird | $225.00 | -20.1% |
| Jan 28, 2026 | Tore Svanberg | Stifel Nicolaus | $215.00 | -23.6% |
| Jan 28, 2026 | Matthew Prisco | Cantor Fitzgerald | $225.00 | -20.1% |
| Jan 28, 2026 | Tom O'Malley | Barclays | $175.00 | -37.8% |
| Jan 22, 2026 | Christopher Rolland | Susquehanna | $225.00 | -20.1% |
| Jan 22, 2026 | David O'Connor | BNP Paribas | $190.00 | -32.5% |
| Jan 15, 2026 | Tom O'Malley | Barclays | $140.00 | -50.3% |
| Jan 15, 2026 | Joe Quatrochi | Wells Fargo | $185.00 | -34.3% |
| Oct 22, 2025 | William Stein | Truist Financial | $175.00 | -37.8% |
| Oct 22, 2025 | Timothy Arcuri | UBS | $245.00 | -13.0% |
| Oct 22, 2025 | Tristan Gerra | Robert W. Baird | $195.00 | -30.7% |
| Oct 22, 2025 | Christopher Rolland | Susquehanna | $200.00 | -28.9% |
| Oct 22, 2025 | James Schneider | Goldman Sachs | $200.00 | -28.9% |
| Jul 28, 2025 | Chris Caso | Wolfe Research | $230.00 | -18.3% |
| Jul 22, 2025 | Timothy Arcuri | UBS | $255.00 | -9.4% |
| Jun 16, 2025 | Joe Quatrochi | Wells Fargo | $190.00 | -32.5% |
| Apr 24, 2025 | Vijay Rakesh | Mizuho Securities | $170.00 | -39.6% |
Top Analysts Covering TXN
TXN vs Sector & Market
| Metric | TXN | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.70 | 2.34 | 2.41 |
| Analyst Count | 40 | 13 | 18 |
| Target Upside | -9.9% | +4072.7% | +14.9% |
| P/E Ratio | 48.11 | 27.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $20.05B | $20.72B | $21.21B | 21 |
| 2027-03-31 | $5.20B | $5.41B | $5.60B | 11 |
| 2027-06-30 | $5.52B | $5.75B | $5.95B | 7 |
| 2027-09-30 | $5.87B | $6.12B | $6.33B | 8 |
| 2027-12-31 | $5.68B | $5.92B | $6.12B | 7 |
| 2028-03-31 | $5.80B | $6.04B | $6.25B | 6 |
| 2028-06-30 | $6.18B | $6.44B | $6.66B | 6 |
| 2028-09-30 | $6.50B | $6.77B | $7.01B | 11 |
| 2028-12-31 | $6.30B | $6.56B | $6.79B | 6 |
| 2029-12-31 | $28.02B | $29.78B | $32.42B | 10 |
| 2030-12-31 | $28.55B | $30.35B | $33.05B | 16 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $7.03 | $7.50 | $7.92 | 22 |
| 2027-03-31 | $1.89 | $2.00 | $2.09 | 10 |
| 2027-06-30 | $2.09 | $2.21 | $2.30 | 7 |
| 2027-09-30 | $2.32 | $2.44 | $2.55 | 7 |
| 2027-12-31 | $2.18 | $2.30 | $2.40 | 14 |
| 2028-03-31 | $2.29 | $2.42 | $2.53 | 11 |
| 2028-06-30 | $2.51 | $2.65 | $2.77 | 8 |
| 2028-09-30 | $2.74 | $2.89 | $3.02 | 8 |
| 2028-12-31 | $2.59 | $2.73 | $2.85 | 15 |
| 2029-12-31 | $10.74 | $11.64 | $12.98 | 11 |
| 2030-12-31 | $11.05 | $11.97 | $13.35 | 5 |
Frequently Asked Questions
What is the analyst consensus for TXN?
The consensus among 40 analysts covering Texas Instruments Incorporated (TXN) is Hold with an average price target of $211.79.
What is the highest price target for TXN?
The highest price target for TXN is $298.00, set by Mark Lipacis at Evercore ISI on 2024-10-23.
What is the lowest price target for TXN?
The lowest price target for TXN is $125.00, set by Tom O'Malley at Barclays on 2025-04-22.
How many analysts cover TXN?
40 analysts have issued ratings for Texas Instruments Incorporated in the past 12 months.
Is TXN a buy or sell right now?
Based on 40 analyst ratings, TXN has a consensus rating of Hold (2.70/5) with a -9.9% upside to the consensus target of $211.79.
What are the earnings estimates for TXN?
Analysts estimate TXN will report EPS of $7.50 for the period ending 2026-12-31, with revenue estimated at $20.72B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.